Emergent BioSolutions Inc...

AI Score

0

Unlock

9.30
-0.06 (-0.64%)
At close: Jan 15, 2025, 1:03 PM

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08 FY07 FY06 FY05 FY04 FY01
Net Income -760.50M -223.80M 230.90M 305.10M 54.50M 62.70M 82.59M 51.78M 62.87M 36.74M 30.26M 18.14M 16.11M 47.18M 26.55M 20.68M 22.94M 22.79M 15.78M 11.47M 230.90M
Depreciation & Amortization 125.10M 143.30M 123.80M 114.50M 110.70M 62.20M 42.57M 38.23M 35.34M 32.45M 18.96M 11.20M 9.36M 5.99M 5.00M 4.96M 4.82M 4.71M 3.55M 1.87M 123.80M
Stock-Based Compensation 23.10M 45.10M 42.40M 51.80M 26.70M 23.20M 15.21M 18.48M 15.85M 12.83M 11.24M 11.12M 10.74M 7.06M 5.01M 2.51M n/a 723.00K n/a n/a 42.40M
Other Working Capital -59.90M -48.30M -61.70M 23.20M -31.50M -16.00M 36.33M 813.00K 4.96M -2.81M -11.28M 9.28M -12.18M -1.65M -1.25M -12.05M 17.72M 10.29M 10.48M -2.85M 94.70M
Other Non-Cash Items 485.20M 19.80M 33.50M 59.00M 37.60M 4.20M 10.78M -14.73M -7.15M 261.00K -1.49M 8.64M 4.68M 6.51M 12.75M -1.47M -3.46M -285.00K -17.00K 491.00K -28.20M
Deferred Income Tax -8.90M -19.00M 46.90M -2.40M -1.60M 8.60M 3.26M 5.19M 3.46M 16.49M 13.86M 3.38M 20.19M 10.93M 7.60M 2.01M 5.59M 987.00K -10.97M -418.00K 46.90M
Change in Working Capital -70.30M 500.00K -156.40M 8.80M -39.90M -119.10M 53.72M -45.45M -65.90M 13.54M 24.14M -12.83M -46.48M 21.87M -26.40M -21.37M 25.54M -32.99M 7.29M -4.46M -94.70M
Operating Cash Flow -206.30M -34.10M 321.10M 536.00M 188.00M 41.80M 208.14M 53.49M 44.46M 112.32M 96.97M 39.64M 14.59M 99.54M 30.51M 7.32M 55.45M -4.06M 42.25M 9.20M 321.10M
Capital Expenditures -51.60M -115.80M -225.00M -141.00M -86.90M -72.10M -54.83M -76.26M -44.81M -30.67M -42.02M -53.84M -54.03M -22.10M -33.29M -20.81M -43.97M -41.23M -6.53M -17.07M -225.00M
Acquisitions 270.20M n/a n/a n/a n/a -827.70M -195.10M n/a -650.00K -179.38M -25.87M n/a n/a -17.87M n/a n/a n/a -218.00K -559.00K n/a n/a
Purchase of Investments n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -4.19M -16.52M n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 1.97M 4.25M 16.52M n/a n/a n/a n/a n/a 147.00K n/a
Other Investing Acitivies -6.30M -265.50M n/a -10.00M -10.00M 2.60M -195.10M n/a n/a n/a -67.89M 11.77M n/a 16.52M n/a -10.00M -43.97M -192.00K 1.25M -1.25M n/a
Investing Cash Flow 212.30M -381.30M -225.00M -151.00M -96.90M -897.20M -249.93M -76.26M -45.46M -210.05M -67.89M -40.11M -53.96M -23.46M -33.29M -30.81M -43.97M -41.64M -5.84M -18.18M -225.00M
Debt Repayment -543.40M 564.20M -35.90M 62.90M 13.70M 795.20M -20.00M n/a 2.00M 180.59M -774.00K 3.32M 12.03M -18.29M 8.54M -751.00K 15.03M 30.86M -956.00K 11.76M n/a
Common Stock Repurchased n/a -82.10M -106.00M -13.80M -7.40M -100.00K -33.10M -1.10M -100.00K -200.00K -213.00K -5.91M n/a 61.20M n/a n/a n/a -192.00K -337.00K -665.00K -106.00M
Dividend Paid n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -5.40M n/a n/a
Other Financial Acitivies -700.00K -900.00K 900.00K 6.60M -49.60M -6.40M 1.70M -18.64M 31.55M 18.49M 9.60M 821.00K 2.22M 1.70M 1.84M 6.33M 995.00K 532.00K n/a -2.42M -141.00M
Financial Cash Flow -535.70M 481.20M -141.00M 69.50M -35.90M 788.70M -51.40M -18.64M 33.45M 198.87M 8.61M -1.76M 14.25M -9.36M 14.84M 8.97M 18.49M 86.02M -6.66M 8.68M -141.00M
Net Cash Flow -530.90M 66.30M -45.20M 453.50M 55.60M -66.90M -93.22M -41.28M 32.30M 101.16M 37.67M -2.23M -25.12M 66.09M 11.45M -14.26M 29.31M 40.12M 29.47M -298.00K -45.20M
Free Cash Flow -257.90M -149.90M 96.10M 395.00M 101.10M -30.30M 153.31M -22.77M -353.00K 81.64M 54.95M -14.20M -39.43M 77.44M -2.78M -13.50M 11.48M -45.29M 35.72M -7.88M 96.10M